Robert W. Schrepfer, VP of Business Advancement, commented, This transaction additional illustrates ANI's ability to execute strategic acquisitions that leverage our internal capabilities and expand our approved item portfolio. We are fortunate to have developed this strategic romantic relationship with a business leader such as for example Teva. .. ANI acquires 22 previously marketed generic drug items for $25 million from Teva Pharmaceuticals ANI Pharmaceuticals, Inc. today announced that it has acquired 22 previously marketed generic drug products from Teva Pharmaceuticals for $25 million in money and a share of future gross income from product sales.Estimates present that as much as two-thirds of ICU individuals are overweight, without any bearing on physical lung size. Those who are the same elevation and gender will have sized lungs similarly, if one weighs more than the other even. Such information can have lasting effects, says Needham. Critical treatment practitioners have to refocus our efforts on not only getting patients out of the ICU alive, but on changing traditional health care in the ICU to improve individuals’ recovery over the long run.